(Press-News.org) CLEVELAND—A combined $1.35 million from the Dr. Ralph and Marian Falk Medical Research Trust was awarded to two researchers from the Case Western Reserve University School of Medicine to advance their work on finding more effective treatments—and better options—for two debilitating diseases.
The Falk Trust awarded Reshmi Parameswaran, an assistant professor in the Department of Medicine, Division of Hematology/Oncology, pathology and pediatrics at the School of Medicine, $1 million over three years for her work in cancer cell therapy.
Carlos Subauste, a professor of medicine and pathology at the School of Medicine, received a two-year, $350,000 grant for his research in diabetic retinopathy, a leading cause of blindness.
Cancer cell therapy
Parameswaran has developed a new treatment strategy for B-cell cancer patients—especially for those who don’t respond to conventional therapies. B-cell lymphoma is a type of cancer that forms in white blood cells.
Many B-cell cancer patients don’t respond to existing therapies, and the disease returns in about half of these patients. Some patients don’t respond at all, while others may initially respond well, but then the disease returns those therapies are ineffective. About 100,000 of the 250,000 B-cell cancer patients diagnosed annually in the United States need a more effective therapy option.
Parameswaran—also a member of the Immune Oncology Program at the Case Comprehensive Cancer Center—is building modified immune cells that have more power to kill cancer cells, without killing normal cells, and minimizing side effects. This cell therapy then could be easily injected into patients.
To build these cells, Parameswaran purifies “Natural Killer (NK)” cells—white blood cells with tumor-killing capabilities. Then a piece of DNA, called “BAFF CAR,” is inserted, which she said gives the NK cells more “specificity” and “power” to kill cancer cells, sparing normal cells.
NK cells from any donor can be used to make BAFF CAR-NK cells, she said, and when a need arises, these specialized cells can be thawed and injected into patients. Her lab hopes to validate the tumor-killing potential and safety of BAFF-CAR NK cells using mouse models with the support from the Falk Trust.
“Both pharmaceutical companies and clinicians treating B cell cancer patients have expressed a strong interest in the BAFF CAR-NK cells as a needed therapeutic,” Parameswaran said. “With this funding, we are optimistic to get this product to the clinic within three years.”
Nearly 700 million people will be diagnosed with diabetes worldwide by 2040, and more than a third will develop diabetic retinopathy, Subauste said.
Diabetic macular edema, caused when blood vessels in the retina leak, is a major reason for progressive loss of vision in diabetic patients.
The disease is treated with eye injections of agents that neutralize what is called Vascular Endothelial Growth Factor (VEGF). But the treatment is only effective in about half of the patients, he said, because other inflammatory molecules can also cause the blood vessels to leak. Anti-VEGF agents only target VEGF, likely explaining why they are partially effective in treating diabetic macular edema.
Subauste and his colleagues are developing a drug that inhibits the molecule CD40, which is known to increase the production of both VEGF and inflammatory molecules in the diabetic retina.
Preliminary studies in the retinas of diabetic mice models suggests this approach may be more effective than monthly injections of anti-VEGF agents.
“Our work is positioned to lead to a novel and more effective way to treat diabetic retinopathy and avoid vision loss, without requiring monthly intra-ocular injections,” he said.
The Dr. Ralph and Marian Falk Medical Research Trust supports biomedical research with two programs: the Catalyst Research Award Program that provides seed funding to develop promising concepts, and the two-year Transformational Research Award to help researchers advance these concepts toward commercial development.
These new awards build on the previous seven Falk Trust awards to Case Western Reserve biomedical researchers, totaling $3.5 million.
About the Dr. Ralph and Marian Falk Medical Research Trust
The Dr. Ralph and Marian Falk Medical Research Trust was created by Marian Falk in 1979 to fund “medical research to improve treatments of the past and eventually find cures for diseases for which no definite cure is known” (Falk Catalyst Awards Program). The Medical Foundation at Health Resources in Action administers the Falk Catalyst Awards Program on behalf of Bank of America, N.A., Trustee.
About Case Western Reserve University
Case Western Reserve University is one of the country's leading private research institutions. Located in Cleveland, we offer a unique combination of forward-thinking educational opportunities in an inspiring cultural setting. Our leading-edge faculty engage in teaching and research in a collaborative, hands-on environment. Our nationally recognized programs include arts and sciences, dental medicine, engineering, law, management, medicine, nursing and social work. About 6,200 undergraduate and 6,100 graduate students comprise our student body. Visit case.edu to see how Case Western Reserve thinks beyond the possible.
Dr. Ralph and Marian Falk Medical Research Trust awards $1.35M to two Case Western Reserve University researchers
Funding will advance novel approaches to treating cancer and diabetes-related blindness
ELSE PRESS RELEASES FROM THIS DATE:
High levels of maternal stress during pregnancy linked to children’s behavior problems
WASHINGTON – Children whose mothers are highly stressed, anxious or depressed during pregnancy may be at higher risk for mental health and behavior issues during their childhood and teen years, according to research published by the American Psychological Association. “Our research suggests that psychological distress during the pregnancy period has a small but persistent effect on children’s risk for aggressive, disinhibited and impulsive behaviors,” said study author Irene Tung, PhD, of California State University Dominguez Hills. “These findings add to the evidence that providing widely accessible mental health care and support ...
Catalyzing clinical change: The importance of representation in health care
DALLAS, November 16, 2023 — Disparities in health care persist, with Hispanic and Black adults reporting less satisfaction with their interactions with physicians, leading to poorer quality of care and health outcomes.,, While 19% of people in the U.S. identify as Hispanic, fewer than 7% of physicians do. This lack of representation in the delivery of health care has been shown to exacerbate health disparities among underrepresented groups and is a significant barrier to the Hispanic Latino community achieving optimal health. In response to this challenge, the American Heart Association, a global force for ...
Lithium-ion batteries are no longer the gold standard in battery tech
The use of lithium metal as the anode for batteries is one of the smarter options with better energy density than other materials. However, the interface between the electrode and electrolyte has quite a few issues that can be addressed for a safer and more functional outcome in the future. The researchers are keen on replacing the graphite anode with lithium metal anode to construct a battery system with higher energy density. However, the Li metal anode is unstable and readily reacting with electrolyte to form a solid-electrolyte interphase (SEI). Unfortunately, the natural SEI is brittle and fragile, resulting in poor ...
Gene splicing reduces effectiveness of CD20-targeting monoclonal antibodies designed to treat variety of blood cancers and disorders
Philadelphia, November 16, 2023 – Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood cancers and hematologic disorders have been treated. However, many patients develop resistance to these treatments due to a loss of the antigen that’s being targeted. Now, a new study from researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn) has found that gene splicing occurring within these cells can cause significant changes in CD20 protein levels that render the therapies ineffective. The findings, published today by ...
IVI signs MOU with University of Cambridge, University of Hong Kong, and the Hong Kong Jockey Club to establish the Hong Kong Jockey Club Global Health Institute
November 16, 2023, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, signed an MOU yesterday with University of Cambridge (UCAM), University of Hong Kong (HKU), and the Hong Kong Jockey Club (HKJC) to promote vaccine research and global health initiatives, including the establishment of the Hong Kong Jockey Club Global Health Institute (HKJCGHI). HKJC will support the HKJCGHI through one of their largest donations in history, ...
Incidence of recurrence and time to recurrence in Stage I to III colorectal cancer
About The Study: In this study of 34,000 patients with colorectal cancer (CRC) who underwent surgery from 2004 to 2019, the risk of recurrence decreased over time, and higher disease stage was associated with shorter times from surgery to recurrence. Screening-detected CRC was associated with a lower risk of recurrence. Because the risk of recurrence was so low in selected patient groups, future research is warranted to explore risk-stratified surveillance protocols in patients with CRC. Authors: Claus Lindbjerg Andersen, Ph.D., of Aarhus University Hospital in Aarhus, Denmark, ...
New efforts to improve cardiovascular, stroke care in rural areas
DALLAS, November 16, 2023 — Cardiovascular mortality is on the rise in rural areas of the United States, where more than 60 million Americans live, according to an American Heart Association presidential advisory. Understanding and addressing the unique health needs of people in rural America is critical to the Association’s pursuit of a world of longer, healthier lives. Today — on National Rural Health Day — the Association, the world’s leading nonprofit organization focused on heart and brain health for all, announces two new collaborative efforts to help close the gap between ...
Make a list, check it twice with these heart-healthy holiday travel hacks
DALLAS, Nov. 16, 2023 — For people living with a health condition like heart disease or stroke, traveling away from home can pose some special challenges. The American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives for all, says with a little pre-travel prep, you can turn travel woes from “oh no” to “let’s go!” “As we look forward to the holidays, many people will be traveling to spend treasured time with family and friends, or maybe just to enjoy some ...
Two new clinical trials find first-ever safe and effective treatment to prevent multidrug-resistant TB in both children and adults: Results presented at the Union Conference in Paris
PARIS (16 November, 2023)—Two landmark clinical trials reported today at the Union meeting showed that an oral antibiotic taken for six months once-daily substantially reduced the risk of developing drug-resistant TB. The antibiotic levofloxacin safely reduced the risk of multidrug-resistant (MDR) tuberculosis (TB) disease in children by 56%, researchers from the Desmond Tutu TB Centre at Stellenbosch University announced at the Union Conference in Paris today. The Unitaid-funded trial also showed that levofloxacin given once ...
AI model can help predict survival outcomes for patients with cancer
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple cancer types. The researchers found that by examining the gene expression patterns of epigenetic factors — factors that influence how genes are turned on or off — in tumors, they could categorize them into distinct groups to predict patient outcomes across various cancer types better than traditional measures like cancer grade and stage. These findings, described in Communications Biology, also lay the groundwork ...
LAST 30 PRESS RELEASES:
New technique efficiently offers insight into gene regulation
U of M Medical School study finds visions of nonphysical world are common among cognitively healthy Ojibwe individuals
Consistency key to corporate expressions of racial solidarity
How mountains affect El Niño-induced winter precipitation
ECHO research examines nutrition data's value from pregnancy to adolescence in understanding child health
Training the immune system to prevent cancer – NextGen researchers discover paradigm-shifting approach
Snail-inspired robot could scoop ocean microplastics
Georgia State professor granted $5 million to identify and characterize objects in space
Immune protein may induce dementia unrelated to high blood pressure
Q&A: How can Canada best meet its commitment to protecting 30% of its land by 2030?
Eating disorder hospitalizations on the rise, affecting 'atypical' groups the most
Brains of newborns aren't underdeveloped compared to other primates
Mortality and morbidity among individuals with hypertension receiving a diuretic, ace inhibitor, or calcium channel blocker
Types of on-screen content and mental health in kindergarten children
Maternal prenatal depressive symptoms and fetal growth during the critical rapid growth stage
About 20% of patients listed as alive in their electronic health records were actually deceased according to California data
Dietary environmental factors shape the immune defense against Cryptosporidium infection
New study maps ketamine's effects on brain
Studies help explain why some prostate cancers become resistant to hormone therapy
Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer
MD Anderson’s Katy Rezvani, M.D., receives 2023 Honorific Award from the American Society of Hematology
Salty immune cells surrounding the brain linked to hypertension-induced dementia
Dark galactic region nicknamed "The Brick" explained with Webb telescope findings
Awareness, accessibility, and affordability are crucial for the early detection of thalassemia
Complications from flu largely preventable with annual flu vaccine
Soil drought weakens forest microclimatic cooling
Study shows advanced footwear technology positively impacts elite sprint performances
What's behind the holiday-suicide myth
More than a meteorite: New clues about the demise of dinosaurs
INU scientists propose a model to predict personal learning performance for virtual reality-based safety training[Press-News.org] Dr. Ralph and Marian Falk Medical Research Trust awards $1.35M to two Case Western Reserve University researchers
Funding will advance novel approaches to treating cancer and diabetes-related blindness